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1. Introduction
  Hepatic hydatid disease is a parasitic infection caused by 
Echinococcus granulosus (Figure 1). It is a public health 
problem in developing countries. The most common location 
of infection in human is the liver[1,2]. The manifestation 
of the disease can range from totally asymptomatic to 
anaphylaxis due to cyst rupture. The percutanous approach 
in the treatment became a promising method to avoid 
complications caused by surgery and longer hospitalisation 
times[3,4]. Our purpose is to demonstrate the utility and the 
safety of the PAIR technique in hydatid disease patients at 
an outpatient basis.
 
Figure 1. Classification of hydatid cysts according to Gharbi and The 
World Health Organization. 59 mm伊47 mm (300伊300 DPI).
Objective: To demonstrate utility and safety of the puncture aspiration injection and reaspiration 
(PAIR) technique for outpatients. Methods: Percutaneous treatment with US guidance was 
applied to 33 patients for 44 cysts. Patients treated with the PAIR technique, were outpatients. 
PAIR and catheterization technique were evaluated for efficacy and safety of procedure and 
complication rates. Results: Thirty-five of 44 cysts were treated with the PAIR and 9 of 44 were 
treated with the catheterization technique. The success rate of the cysts Gharbi type 1 (CE1) and 
type 2 (CE3a) treated with the PAIR technique was 100%. In the follow up of 9 cysts treated with 
the catheterization technique, 2 of them (22%) developed cyst infection and 1 (11%) developed a 
biliary fistula. Conclusions: The PAIR technique was found to be an effective and safe approach 
in order to treat Gharbi type 1 and type 2 cysts percutaneously for outpatients. It has a very low 
complication rate in comparison with the catheterization technique. So every effort should be 
made to finish the treatment with PAIR technique.
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2. Material and methods
2.1. Patient information
  Within a 5 year period, between 2005 and 2010, 33 
consecutive patients (26 female and 7 male) were included 
in our study. The mean age was 41.8 (13-77) years old. In 6 
patients there were multiple cysts in the pre-interventional 
ultrasonography examination. Forty-four cysts were planned 
for the intervention in 33 patients.  
2.2. Treatment procedures
  Puncture, aspiration injection re-aspiration (PAIR) technique
and the catheterization techniques were performed 
percutaneously. In the PAIR technique, the cyst was 
punctured with 18 G Seldinger needle under US guidance. 
Using the color Doppler US the vessels in the entry side for 
the intervention were carefully detected in order to avoid 
them. In the first entry, 90% of the cyst content was aspirated 
with the needle. Then radiopaque material (ionic, meglumine 
and sodium-ioxytalamate, 350 mg/mL; Telebrix-35®, 
Guerbet, Cedex, France) as much as 10%-20% of the cyst 
volume was given.  Then 30% hypertonic saline infusion with 
an amount of the 60%-70% of the former cyst volume was 
given.  After 15 min the cyst liquid was re-aspirated (Figure 
2).  Then again with fluoroscopy guidance the radiopaque 
material as much as 10%-20% of the cyst volume was given 
to make sure that there was no leakage outside from the cyst 
to the peritoneum and to the biliary tract. This is followed 
by injection of 96% ethanol with a volume of 60%-70% of the 
cyst volume for sclerosing and scolicidal purposes. Ethanol 
was aspirated after 15 min. All hypertonic saline and ethanol 
injections were done under fluoroscopic control. The most 
important disadvantage of the PAIR technique is that the 
injected hypertonic saline and alcohol cannot be aspirated 
due to the separating membranes in some patients. In these 
patients, when necessary, with real-time US guidance the 
rest fluid was completely aspirated. One important point was 
that the separating membranes of the cyst could plug the 18 G
Seldinger needle in a check valve manner and to overcome 
this problem the 20 G needle was advanced into cyst through 
18 G needle coaxially and the liquid was aspirated under US 
guidance. Sometimes the first needle was connected to a line 
for free drainage, this also can help to overcome check valve 
manner blockage of the needle. If needed second or third 
needle (mostly 21 G) was inserted into the cyst cavity with 
another puncture. While performing these manures the first 
needle was always kept in place to avoid leakage. Therefore 
almost all cysts were aspirated fully or almost fully with 
success.
  If a cysto-biliary fistula is detected or if the cyst fluid 
could not be evacuated despite all these measures, 
catheterization technique is used. In the catheterization 
technique, 30% hypertonic saline injection was made in to 
the cyst cavity under US and fluoroscopic guidance. After 
waiting for 15 min and aspiration, a 8 French pigtail catheter 
(Flexima, Boston Scientific, USA) was inserted into the cyst 
cavity and this stayed there for 24 h for the drainage (Figure 
3). Then cytsography was performed in order to detect a 
possible fistula between the cyst cavity and biliary tract. In 
the patients with no fistula 95% ethanol with an amount of 
the half of the former cyst volume was given into the cyst 
cavity. To maximize the sclerosing and scolicidal effect of 
the ethanol, it was applied for 15 min. In patients with fistula 
between the biliary tract and the cyst cavity, the ethanol 
was not used in order to avoid the risk of sclerosing the bile 
ducts.
  Samples from the cyst content were used for the cytological 
and microbiological tests. In all patients the diagnosis of the 
hydatid disease was confirmed by the direct microscopic 
analysis, high pressure content coming during the 
intervention, double layer in the ultrasonography, presence 
of separating membranes or daughter cysts.
  The prophylactic albendazol therapy (Andazol 200 mg tb 2
伊2) minimum 10 d before and 30 d after the in intervention 
was given to all patients.
 
Figure 2. 29 year old man with percutaneously treated Gharbi type 1 
hepatic hydatid cyst.
Cystogram obtained 4-5 min after injection of hypertonic saline 
solution reveals endocyst separated (arrows) from pericyst (A). After 
15 minutes the cyst liquid was re-aspirated (B). 40 mm伊36 mm (300伊
300 DPI).
After 15 min the cyst liquid was re-aspirated (B). 43 mm伊43 mm (300
伊300 DPI).
3. Results
  Forty-four cysts in 33 patients were treated. Thirty-five 
of 44 cysts were treated with the PAIR technique while 
remaining 9 of them were treated with the catheterization 
technique. The PAIR and the catheterization technique 
were applied in all the patients with a technical success 
rate of 100%. According to the Gharbi classification 22 
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cysts were Gharbi type 1 (CE1), 16 cysts were Gharbi type 2 
(CE3a) and 6 cysts were Gharbi type 3 (CE2). Twenty Gharbi 
type 1 (CE1) cysts were treated with the PAIR technique, 
whereas remaining 2 Gharbi type 1 cysts were treated with 
the catheterization technique. Four Gharbi type 2 (CE3a) 
cysts were treated with the catheterization technique and 
12 Gharbi type 2 (CE3a) cysts were terated with the PAIR 
technique. Three Gharbi type 3 (CE2) cysts were treated with 
the catheterization and the remaining 3 Gharbi type 3 (CE2) 
cysts were treated with the PAIR technique. The need for the 
catheterization increased as we go further from the type 1 to 
type 3 because of the problems such as the relation of the 
cysts with the biliary tract and since sometimes the given 
liquids could not be aspirated.
  The mean cyst volume before the intervention was 413.7 
(10-3 300) mL. It became 59.2 (2-500) mL after intervention. 
Mean volumes of the cysts treated with the catheterization 
technique were 1 501.6 (450-3 300) mL and 226.6 (40-500) mL 
before and after intervention, respectively.  Mean volumes 
of cysts treated with the PAIR technique were 113.9 (10-
528) mL and 16.1 (2-60) mL before and after intervention, 
respectively. The mean volume of cysts was reduced to 14%-
15% of their initial volume.  These percentages were 11%-
12% and 15%-16% for cysts treated with the PAIR technique 
and the catheterization technique, respectively.
  The mean follow up time was 48.1 (9-104) month. The 
patients who were treated with the PAIR technique needed 
no hospitalization at all. The hospitalization period for the 
patients treated with the catheterization technique was 
27.3 (12-48) days at average. In one patient treated with 
catheterization technique we found a growing cyst and this 
patient was treated with re-catheterization.
  The success rate of the patients with the cysts of Gharbi 
type 1(CE1) and 2 (CE3a) treated with the PAIR technique 
was 100%. One of the 3 Gharbi type 3 cysts (CE2) treated 
with the PAIR technique had a recurrence. In all patients 
treated with the PAIR technique there was no other major 
complications such as abdominal dissemination, cyst 
infection, abcess or bleeding in the cyst. Nine patients with 
cysts type of 1, 2 and 3 were treated with the catheterization 
technique. In 3 of them (33.3%) there were complications. 
Two patients (22.0%) had cyst infections and in one patient 
(11.0%) biliary fistula developed.  Among 2 patients with cyst 
infections one patient had type 1 (CE1) and the other had 
type 3 (CE2) cysts.  One patient with the biliary fistula had 
Gharbi type 3 cyst (CE2).  Only one patient (2.8%) from the 
PAIR group with 35 cysts had the recurrence. In this patient 
with the recurrence, cyst was Gharbi type 3 (CE 2).  There 
was no other complication.
  Ultrasonography was used pre and post interventionally 
to assess and to follow up the patients. No MRI or CT was 
needed.
 
Figure 3. 82 year old women with percutaneously treated giant 
hepatic hydatid cyst (A). This patient was treated with catheterization 
(B). 43 mm伊43 mm (300伊300 DPI).
This patient was treated with catheterization (B). 43 mm伊43 mm (300
伊300 DPI).
4. Discussion
  The main goal of the hydatid disease treatment is to 
relieve the syptoms and to avoid the complications such 
as infections, obstructive jaundice and anaphylactic shock 
all of which can be caused by the cyst rupture.  The most 
commonly affected organ in the hydatid disease is the liver 
but many other organs can also be affected. Nowadays the 
treatment approaches of hydatid disease can be surgical, 
percutaneus or medical[5,6].
  The surgical approach has been the gold standard 
therapy for the hydatid disease for long years[5]. However, 
the location and smaller volumes of some cysts make the 
surgical approach unfeasible. Moreover, cysto-biliary fistula 
is the most common complication of the hydatid disease 
affecting the liver[7] and formerly the surgical approach 
was preferred in the presence of a fistula which is a result 
of a cyst rupture to the biliary tree. But nowadays the 
percutaneous approach is possible for such conditions[6]. 
The medical therapy is not effective in most cases. However 
it is used in pre-and post surgically and interventionally, for 
theoretical risk of the abdominal dissemination in order to 
keep them under the secondary prophylaxis[8-10].
  Developing minimal invasive techniques has ensured the 
percutaneous treatment of the hydatid disease without need 
for surgery. The PAIR and catheterization techniques were 
used for the percutaneous therapy[11,12]. The percutaneous 
therapy has low complication rates of 13.3% for minor and 
5% for major complications. Especially in the cysts of type 
1 (CE1) and 2 (CE3a) the PAIR technique was found effective 
and safe in long term in the treatment for the hydatid cyst 
disease. In the cysts of type 3 (CE2) the success rate was 
somewhat lower (39%) (13). In our study, especially in the 
cysts of type 1 (CE1) and 2 (CE3a) the success rate with the 
PAIR technique was 100%. On the other hand there was 
only one case (2.8%) of recurrence in a cyst of Gharbi type 
3 (CE2). In a study investigating the Double Puncture-
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Aspiration-Injection technique, the morbidity rate was 8.6% 
and the mortality rate was 0.9%. One patient in that study 
had anaphylactic shock. As major complication (2.5%) one 
patient had intra-cystic bleeding and in two cysts liver 
abcess developed. In one patient a biliary fistula was found. 
The average hospitalization time in that study was 2.9 days 
(2-7 days)[4].  In our study the PAIR approach was performed 
for outpatients and there was neither intra-cyst bleeding nor 
infection or biliary fistula. Only one patient had recurrence 
and this patient was treated successfully eventually.
  In the type 3 (CE2) cysts and with the catheterization 
technique the irrigation was made with saline and betadine 
(10% povidone iodine; 1% free iodine) on daily basis. 
There was no recurrence[14]. In our study there was no 
recurrence with the catheterization technique.  However the 
complication rate of the catheterization technique (33.3%) 
was more than that of the PAIR technique. In comparison 
with the catheterization technique, the PAIR technique has 
the advantage of no need for hospitalization and having the 
patients treated as outpatients. Moreover, it is less invasive 
than the catheterization technique. When the duration of the 
catheterization gets longer, the risks of catheter tract and the 
cyst infection increase. Additionally, during and after such 
an intervention, risk of developing hematoma and bleeding 
is higher and the duration of the hospitalization increases if 
the catheter is used.  All these reasons make us to conclude 
that the overall comfort of the patients treated with the PAIR 
technique is better than those treated with the catheterization 
technique.  In our study in one patient (2.8%) treated with the 
PAIR technique there was a recurrence in the follow up. Two 
patients (22.0%) treated with the catheterization technique 
had cyst infection and one patient (11.0%) treated with 
the catheterization technique got biliary fistula. The most 
important disadvantage of the PAIR technique was that the 
hypertonic saline infusion and the injected alcohol cannot 
be aspirated due to seperating membranes. This may result 
in a change to the catheterization technique. But before 
changing into catheterization technique every effort should 
be made to finish the treatment with PAIR technique.
  Our study had few limitations worth to mention. First, we 
had a relatively small patient population and the patient 
populations for PAIR and catheterization groups were not 
matching one to one. However, it is quite difficult to run a 
one to one matching trial in such a clinical entity. Secondly, 
our follow up time is not long, but our group is trying to 
accumulate more patients with longer follow up duration.
  As a conclusion, to the best of our knowledge, this is the 
first study confirming that the hydatid disease can be treated 
minimal invasively with the PAIR technique without need 
for hospitalization. The PAIR technique is effective and 
safe with lower complication rates. So every effort should 
be made to finish the treatment with PAIR technique. 
Especially in Gharbi type 1 (CE1) and type 2 (CE3a) cysts the 
success rate is higher with the PAIR technique and such 
patients can be treated as outpatients.
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